Cargando…
Diagnostic utility of a Ferritin-to-Procalcitonin Ratio to differentiate patients with COVID-19 from those with Bacterial Pneumonia: A multicenter study
IMPORTANCE: There is a need to develop tools to differentiate COVID-19 from bacterial pneumonia at the time of clinical presentation before diagnostic testing is available. OBJECTIVE: To determine if the Ferritin-to-Procalcitonin ratio (F/P) can be used to differentiate COVID-19 from bacterial pneum...
Autores principales: | Gharamti, Amal A., Mei, Fei, Jankousky, Katherine C., Huang, Jin, Hyson, Peter, Chastain, Daniel B., Fan, Jiawei, Osae, Sharmon, Zhang, Wayne W., Montoya, José G., Erlandson, Kristine M., Scherger, Sias J., Franco-Paredes, Carlos, Henao-Martínez, Andrés F., Shapiro, Leland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587841/ https://www.ncbi.nlm.nih.gov/pubmed/33106821 http://dx.doi.org/10.1101/2020.10.20.20216309 |
Ejemplares similares
-
Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study
por: Gharamti, Amal A, et al.
Publicado: (2021) -
419. Diagnostic Utility of a Ferritin to Procalcitonin Ratio to Differentiate Patients with COVID-19 from Those with Bacterial Pneumonia
por: Jankousky, Katherine C, et al.
Publicado: (2020) -
Anakinra authorized to treat severe coronavirus disease 2019; Sepsis breakthrough or time to reflect?
por: Shapiro, Leland, et al.
Publicado: (2023) -
Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis
por: Shapiro, Leland, et al.
Publicado: (2022) -
Association between cytokine levels, sepsis severity and clinical outcomes in sepsis: a quantitative systematic review protocol
por: Gharamti, Amal, et al.
Publicado: (2021)